Six types of prescription drugs for treating heart disease and hypertension registered under Taiwanese pharmaceutical companies are being recalled as a precaution, as they could contain a probable carcinogen, the Food and Drug Administration (FDA) said yesterday.
The announcement came after governments in Hong Kong, Macau, the UK and several other countries ordered recalls of anti-hypertensive drugs containing valsartan produced by Zhejiang Huahai Pharmaceutical Co Ltd (浙江華海製藥公司) in China.
N-nitrosodimethylamine, a chemical classified as a probable human carcinogen based on laboratory test results, was detected in the valsartan.
Photo: CNA
The FDA on Saturday said that the recalled products registered under pharmaceutical company Actavis Generics were not imported to Taiwan.
However, after a preliminary examination of drugs containing valsartan that are registered in Taiwan, it discovered that six products contain valsartan from Huahai Pharmaceutical Co.
The products being recalled are: Valsart FC Tablet 160mg and Valsart FC Tablet 80mg registered to Standard Chemical and Pharmaceutical Co Ltd (生達化學製藥); Kovan Plus Coated Tablets 80/12.5mg registered to Macro Co Ltd (瑪科隆); Valsardin Film Coated Tablet 160mg and Valsardin Film Coated Tablet 80mg registered to Yung Shin Pharmaceutical Industrial Co (永信藥品); and Valen FC Tablet 160mg registered to Purzer Pharmaceutical Co Ltd (瑞安大藥廠).
The six products that are being recalled account for about 3 to 4 percent of their category in Taiwan, so the majority of heart disease patients do not have to panic, FDA official Chi Jo-feng (祁若鳳) said.
Healthcare facilities and pharmacies have been told to recall the products within a month, the FDA said, adding that patients taking the recalled drugs should not to stop taking them, but rater see a doctor as soon as possible for an alternative prescription.
RESOLUTIONS DEBATE: Taiwan’s allies said that UN and WHA resolutions cited by China and other nations ‘do not determine Taiwan’s participation in WHO activities’ A proposal to invite Taiwan to this year’s World Health Assembly (WHA) was rejected on Monday, resulting in Taipei’s absence from the annual meeting for a ninth consecutive year, although partners spoke up for Taiwan’s participation at the first day of the meeting. The first agenda item after the opening was a “two-on-two debate” on a proposal to invite Taiwan to participate at the WHA as an observer. Similar to previous years, two countries made statements in favor of the proposal, while two others expressed their opposition. Philippine Secretary of Health Teodoro Herbosa, president of the 78th WHA, accepted the WHA General Committee’s
Palauan President Surangel Whipps Jr arrived in Taiwan last night to kick off his first visit to the country since beginning his second term earlier this year. After arriving at Taoyuan International Airport at around 6:30 pm, Whipps and his delegation were welcomed by Minister of Foreign Affairs Lin Chia-lung (林佳龍). Speaking to gathered media, the Palauan leader said he was excited and honored to be back in Taiwan on his first state visit to Taiwan since he was sworn in this January. Among those traveling with Whipps is Minister of State Gustav N. Aitaro, Public Infrastructure
Premier Cho Jung-tai (卓榮泰) on Friday laid out the Cabinet’s updated policy agenda and recapped the government’s achievements ahead of the one-year anniversary of President William Lai’s (賴清德) inauguration. Cho said the government had made progress across a range of areas, including rebuilding Hualien, cracking down on fraud, improving pedestrian safety and promoting economic growth. “I hope the public will not have the impression that the Cabinet only asked the legislature to reconsider a bunch of legal amendments,” Cho said, calling the moves “necessary” to protect constitutional governance and the public’s interest. The Cabinet would work toward achieving its “1+7” plan, he said. The
Nvidia founder and CEO Jensen Huang (黃仁勳) hosted a dinner in Taipei last night with key Taiwanese suppliers to celebrate the successful mass production of the company’s new Blackwell AI systems. Speaking to the media earlier yesterday, Huang thanked Nvidia’s Taiwanese partners for their contributions to the company’s ecosystem, while also sharing his plans to meet with Taiwan Semiconductor Manufacturing Co (TSMC) founder Morris Chang (張忠謀). In response to rumors that Nvidia will launch a downgraded Hopper H20 chip for China in July, Huang dismissed the reports, saying, “That is not true.” He clarified that there
RSS